EcoDrugPlus


Synonyms	Antidotum-thallii-heyl Ferric Hexacyanoferrate(II) Ferric ferrocyanide Ferric hexacyanoferrate Ferric hexacyanoferrate(ii) Ferrum cyanatum Insoluble prussian blue Iron(iii) ferrocyanide NSC-8665 Prussian Blue Prussian blue Prussian blue insoluble Radiogardase Radiogardase (prussian blue) Radiogardase-cs
Status
Molecule Category	UNKNOWN

Synonyms

Antidotum-thallii-heyl

Ferric Hexacyanoferrate(II)

Ferric ferrocyanide

Ferric hexacyanoferrate

Ferric hexacyanoferrate(ii)

Ferrum cyanatum

Insoluble prussian blue

Iron(iii) ferrocyanide

NSC-8665

Prussian Blue

Prussian blue

Prussian blue insoluble

Radiogardase

Radiogardase (prussian blue)

Radiogardase-cs

Status

Molecule Category

UNKNOWN


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Property Name	Value
Molecular Formula	C18Fe7N18
Molecular Weight	859.24
AlogP	None
Hydrogen Bond Acceptor	None
Hydrogen Bond Donor	None
Number of Rotational Bond	None
Polar Surface Area	None
Molecular species	None
Aromatic Rings	None
Heavy Atoms	None

Property Name

Value

Molecular Formula

C18Fe7N18

Molecular Weight

859.24

AlogP

None

Hydrogen Bond Acceptor

None

Hydrogen Bond Donor

None

Number of Rotational Bond

None

Polar Surface Area

None

Molecular species

None

Aromatic Rings

None

Heavy Atoms

None

Mechanism of Action	Action	Reference
Radioactive metals chelating agent	CHELATING AGENT	FDA

Mechanism of Action

Action

Reference

Radioactive metals chelating agent

CHELATING AGENT

FDA

Resources	Reference
ChEMBL	CHEMBL2096629

Resources

Reference

ChEMBL

CHEMBL2096629


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PRUSSIAN BLUE INSOLUBLE

Physicochemical Descriptors

Bioactivity

Cross References